BEIJING and BURLINGTON, Mass., Oct. 16, 2023 /PRNewswire/ — CANbridge Pharmaceuticals Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development and commercialization of transformative therapies to treat rare disease and rare…